Microbot Medical Inc. Announces Significant Technology Patent Allowance in the U.S.
Two of the inventors include the Company’s co-founders,
Microbot’s latest patent covers systems and methods for reducing venous stenosis associated with the use of hemodialysis shunts. A clearing device is inserted through a first bore, while dialyzed blood is being returned into the blood vessel through a second bore. The clearing device may be a passive device moved down the blood vessel by the blood flow or an autonomous crawling device, such as Microbot's TipCat™ device, which is based on a series of sequentially inflatable chambers. This new patent provides an additional layer of protection to Microbot's innovative TipCat™ and ViRob™ platforms, extending beyond their current IP protected applications.
"We continue to focus on strengthening our unique intellectual property (IP) assets. The patent allowance issued to Microbot by the USPTO further protects our medical devices for the prevention of shunt stenosis and will enhance our future positioning within the shunt market,” commented Mr. Gadot. “We intend to continue to strengthen our IP as we grow our transformational micro-robotic technologies to treat and diagnose serious medical conditions as well as improve and extend the quality of life for the patients suffering from those conditions.”
The Company will ring the Nasdaq Closing Bell at the Nasdaq MarketSite in
Microbot was founded in 2010 and became a NASDAQ listed company on
The ViRob technology is a revolutionary autonomous crawling micro-robot which can be controlled remotely or within the body. Its miniature dimensions allow it to navigate and crawl in different spaces within the human body, including blood vessels, the digestive tract and the respiratory system. Its unique structure gives it the ability to move in tight spaces and curved passages as well as the ability to remain within the human body for prolonged time. To learn more about ViRob please visit http://www.microbotmedical.com/technology/virob/.
TipCAT is a transformational self-propelled, flexible, and semi-disposable endoscope providing see & treat capabilities within tubular lumens in the human body such as the colon, blood vessels, and the urinary tract. Its locomotion mechanism is perfectly suitable to navigate and crawl through natural & artificial tubular lumens, applying the minimal necessary pressure to achieve the adequate friction required for gentle, fast, and safe advancement within the human body. To learn more about TipCAT visit http://www.microbotmedical.com/technology/tipcat/.
Statements pertaining to future financial and/or operating results, future growth in research, technology, clinical development, and potential opportunities for
Investor Contact: EVC Group
Michael Polyvioumpolyviou@evcgroup.com 212-850-6020; 646-445-4800